Myriad Genetics | MYGN - Los Gastos De Explotación

Precio De Mercado
4.71
Cambio Diario
0.13 2.84%
Mensual
7.53%
Anual
-52.95%
Q1 Expectativa
4.44




Los Gastos De Explotación Cambio Fecha
Agilent USD 1.44B 27M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Bio-Rad Laboratories USD 6.74B 6.16B 2025-09
Bruker USD 900.9M 124.3M 2025-12
Danaher USD 5.34B 45.74B 2025-12
Exact Sciences USD 875.74M 62.51M 2025-09
Hologic USD 349.4M 447.1M 2025-12
Illumina USD 903M 69M 2025-12
J&J USD 18.97B 2.38B 2025-12
Mettler Toledo International USD 777.8M 42.3M 2025-12
Myriad Genetics USD 212.8M 16.2M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Pacific Biosciences Of California USD 97.83M 41.29M 2025-12
Quest Diagnostics USD 2.42B 4.84B 2025-12
Quidel USD 760.9M 1.28B 2025-12
Repligen USD 177.94M 1.82M 2025-12
Revvity USD 626.22M 25.62M 2025-12
Standard Biotools USD 45.72M 2.7M 2025-12
Thermo Fisher Scientific USD 9.91B 867M 2025-12
Veracyte USD 116M 7.24M 2025-12
Waters USD 661.85M 1.67B 2025-12